KFBK & NPR Interviews with CGT Global

CGT Global the future of healthcare - Final mile to the patient

THE FUTURE OF HEALTHCARE Our own Cate Spears, CEO and founder of CGT Global, was just interviewed on two major news media outlets.  Nationally recognized broadcaster Cristina Mendosa from KFBK and Vicki Gonzales from NPR‘s CapRadio. Both interviews discuss our innovative collaboration to deliver cell and gene therapies across the globe. LISTEN NOW We encourage…

For More Information

Top-Tier Quality

Top Tier Quality Products and services

TOP-TIER QUALITY  Biotechnology is a rapidly evolving industry which has the potential to revolutionize the Healthcare field. As the biotechnology industry continues to advance ensuring the safety, efficacy and quality of the products and processes are maintained at every step becomes critical to everyone in the field.  This is where CGT Global plays a pivotal…

For More Information

Partnership Newsflash

CGT Global and Octomera have entered into an agreement

CGT GLOBAL SELECTED AS STRATEGIC PARTNER TO EXPAND CELL AND GENE THERAPIES ACROSS THE UNITED STATES CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has cell and gene therapy mobile laboratories currently…

For More Information

Meet our Laboratory Team

CGT Global: Peel into our laboratory's expertise

  CGT Global is thrilled to introduce you to the incredible members of our laboratory team who make the magic happen every day. Bryan: The Fearless Leader With an analytical mind and a passion for innovation, Bryan spearheads our lab projects, ensuring precision and excellence in every isolation and custom project. Eliona: The Hotshot Scientist…

For More Information

Webinar: Access to Cell and Gene Therapies

Thumbnail image - Webinar playback

Addressing Disparities in Access to Cell and Gene Therapies We are thrilled to share the fantastic outcome of our recent webinar, ” Addressing Disparities in Access to Cell and Gene Therapies.” The engagement and insightful discussions during the session were truly remarkable, and we want to extend our heartfelt gratitude to all who participated. Missed…

For More Information